Recent lawsuits on mRNA technology are attempts by various corporations to take control of these vital discoveries for their own enrichment. Recent advances in molecular technology that allows for gene editing and protein manufacturing portend a revolution in medicine that can offer personalized treatments for a broad array of diseases.
Only recently appreciated as critical components of cellular functions, unstructured stretches of amino acids called SLiMs are key to viral-host interactions.